Ibritumomab Tiuxetan and Sinemet CR 200/50
Determining the interaction of Ibritumomab Tiuxetan and Sinemet CR 200/50 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Sinequan
- Ibritumomab Tiuxetan-Sinequan (Doxepin Capsules)
- Ibritumomab Tiuxetan-Sinequan (Doxepin Oral Concentrate)
- Ibritumomab Tiuxetan-Sinex Long-Acting
- Ibritumomab Tiuxetan-Sinex Nasal Spray
- Ibritumomab Tiuxetan-Singulair
- Sinemet CR 200/50-Ibrutinib
- Sinemet CR 200/50-Ibrutinib Capsules
- Sinemet CR 200/50-Ibrutinib Tablets
- Sinemet CR 200/50-Ibu
- Sinemet CR 200/50-IBU Tablets
- Sinemet CR 200/50-Ibu-2